BACKGROUND: Uterine fibroids (UF) are commonly associated with heavy menstrual bleeding (HMB) and anemia; however limited data are available on the prevalence of anemia in women with UF, with or without HMB, and the additional incremental b…
Objective: Present the treatment journey of women with endometriosis and associated healthcare resource utilization (HCRU) and costs. Design: Retrospective claims data analysis. Setting: January 1, 2016, to December 31, 2021, Merative™ Mark…
BACKGROUND: Limited evidence is available regarding preferences of women with uterine fibroids (UF) and treating healthcare providers (HCPs) regarding treatment attributes; this evidence could contribute to patient-centered shared decision-…
BACKGROUND: Historically, the clinical characteristics and treatment pathways for patients with uterine fibroids and heavy menstrual bleeding have differed between White and Black women. OBJECTIVE: To provide a contemporary comparison of p…
INTRODUCTION: This retrospective database claims analysis describes the clinical characteristics and treatment patterns of commercially insured United States women with uterine fibroids (UF) and heavy menstrual bleeding (HMB). METHODS: Wom…
Background: This retrospective database analysis describes clinical characteristics and treatment patterns of U.S. women with a diagnosis for uterine fibroids (UF), both with and without heavy menstrual bleeding (HMB). Materials and Methods…